<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">We understand that many cancer scientists may want to temporarily focus their attention on contributing to COVID-19 research. To facilitate such work where appropriate, we have announced several funding opportunities and the option of for redirecting current grant resources to COVID-19-related projects that are cancer relevant and can be initiated immediately (
 <xref rid="tbox1" ref-type="boxed-text">Box 1</xref> ).
 <boxed-text id="tbox1">
  <label>Box 1</label>
  <caption>
   <title>NCI COVID-19 Funding Opportunities</title>
  </caption>
  <p id="p0160">Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19): NOT-CA-20-043</p>
  <p id="p0165">Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19): NOT-CA-20-042</p>
  <p id="p0170">Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)”: NOT-CA-20-048</p>
  <p id="p0175">Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-19-Related Research during the Crisis: NOT-CA-20-054</p>
  <p id="p0180">Please visit 
   <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/coronavirus-researchers" id="intref0010" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.cancer.gov/coronavirus-researchers</ext-link> for more information.
  </p>
 </boxed-text>
</p>
